glp 1 analogue moa Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Mechanism of action of GLP-1
Description
A retrospective disproportionality analysis was conducted using the reporting odds ratio (ROR) on FAERS data (20042024), with Bayesian confidence propagation neural network (BCPNN) employed for sensitivity analysis
Beyond improving glycemic control, these therapies promote weight loss and lower blood pressure when used individually, and in an additive manner when used together
Smaller meals, hydration, slower dose increases, and better timing can often reduce it.
Prep once, eat for weeks.
Initially
